Tech Company Financing Transactions
Celleration Funding Round
On 5/8/2008, Celleration landed $25 million in Series C funding from Aavin Equity Advisors, Baird Capital and New Science Ventures.
Transaction Overview
Company Name
Announced On
5/8/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6321 Bury Dr. 15
Eden Prairie, MN 55346
USA
Eden Prairie, MN 55346
USA
Phone
Website
Email Address
Overview
The patented MIST Therapy System from Celleration is an innovative, painless ultrasound noncontact wound healing device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Wagner
Chief Financial Officer
Christopher Geyen
VP - Manufacturing
Terri Grant
VP - R & D
Douglas Duchon
Browse more venture capital transactions:
Prev: 5/7/2008: Spot Runner venture capital transaction
Next: 5/8/2008: Giant Realm venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs